Antidepressants/propofol/valproic-acidParalysis with anaesthesia awareness with recall following pharmacodynamic drug-drug interaction: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1971卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45154-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：29 / 29

相关论文

共 50 条

[1] Multiple drugsSevere serotonin syndrome following pharmacodynamic drug-drug interaction: case report
Reactions Weekly, 2024, 2030 (1) : 357 - 357
[2] Multiple drugsPneumonitis following drug-drug pharmacodynamic interaction and lack of efficacy: case report
Reactions Weekly, 2024, 2029 (1) : 470 - 470
[3] Empagliflozin/TirzepatideEuglycaemic diabetic ketoacidosis following drug-drug pharmacodynamic interaction: case report
Reactions Weekly, 2024, 2039 (1) : 205 - 205
[4] Hydroxychloroquine/Prednisone/TerbinafineExacerbation of psoriasis following drug-drug pharmacodynamic interaction: case report
Reactions Weekly, 2024, 2039 (1) : 252 - 252
[5] Antidepressants/Antipsychotics/valproic acidHyperammonaemic encephalopathy following drug interaction: case report
Reactions Weekly, 2020, 1828 (1) : 59 - 59
[6] Phenytoin/valproic-acidPhenytoin toxicity following drug-drug pharmacokinetic interaction: case report
Reactions Weekly, 2021, 1880 (1) : 324 - 324
[7] Multiple drugsCutaneous erythema and pharmacodynamic drug-drug interaction: case report
Reactions Weekly, 2025, 2045 (1) : 253 - 253
[8] Dexmedetomidine/octreotideSinus arrest and drug-drug pharmacodynamic interaction: case report
Reactions Weekly, 2024, 2029 (1) : 221 - 221
[9] Multiple drugsNeutropenia following drug-drug pharmacodynamic interaction: 10 case reports
Reactions Weekly, 2025, 2040 (1) : 731 - 731
[10] Lamotrigine/Sodium-valproatePruritic morbiliform rash following drug-drug pharmacodynamic interaction: case report
Reactions Weekly, 2025, 2040 (1) : 510 - 510

← 1 2 3 4 5 →